224 related articles for article (PubMed ID: 38141214)
1. Ten years of using key characteristics of human carcinogens to organize and evaluate mechanistic evidence in IARC Monographs on the identification of carcinogenic hazards to humans: Patterns and associations.
Rusyn I; Wright FA
Toxicol Sci; 2024 Feb; 198(1):141-154. PubMed ID: 38141214
[TBL] [Abstract][Full Text] [Related]
2. Ten Years of Using Key Characteristics of Human Carcinogens to Organize and Evaluate Mechanistic Evidence in IARC Monographs on the Identification of Carcinogenic Hazards to Humans: Patterns and Associations.
Rusyn I; Wright FA
bioRxiv; 2023 Jul; ():. PubMed ID: 37503163
[TBL] [Abstract][Full Text] [Related]
3. Key characteristics of 86 agents known to cause cancer in humans.
Krewski D; Bird M; Al-Zoughool M; Birkett N; Billard M; Milton B; Rice JM; Grosse Y; Cogliano VJ; Hill MA; Baan RA; Little J; Zielinski JM
J Toxicol Environ Health B Crit Rev; 2019; 22(7-8):244-263. PubMed ID: 31637961
[TBL] [Abstract][Full Text] [Related]
4. Prioritizing cancer hazard assessments for IARC Monographs using an integrated approach of database fusion and text mining.
Barupal DK; Schubauer-Berigan MK; Korenjak M; Zavadil J; Guyton KZ
Environ Int; 2021 Nov; 156():106624. PubMed ID: 33984576
[TBL] [Abstract][Full Text] [Related]
5. Overview of biological mechanisms of human carcinogens.
Birkett N; Al-Zoughool M; Bird M; Baan RA; Zielinski J; Krewski D
J Toxicol Environ Health B Crit Rev; 2019; 22(7-8):288-359. PubMed ID: 31631808
[TBL] [Abstract][Full Text] [Related]
6. How well can carcinogenicity be predicted by high throughput "characteristics of carcinogens" mechanistic data?
Becker RA; Dreier DA; Manibusan MK; Cox LAT; Simon TW; Bus JS
Regul Toxicol Pharmacol; 2017 Nov; 90():185-196. PubMed ID: 28866267
[TBL] [Abstract][Full Text] [Related]
7. The Monographs Programme of the International Agency for Research on Cancer. A brief history of its Preamble.
Baan RA; Straif K
ALTEX; 2022; 39(3):443–450. PubMed ID: 34164695
[TBL] [Abstract][Full Text] [Related]
8. Use of high-throughput in vitro toxicity screening data in cancer hazard evaluations by IARC Monograph Working Groups.
Chiu WA; Guyton KZ; Martin MT; Reif DM; Rusyn I
ALTEX; 2018; 35(1):51-64. PubMed ID: 28738424
[TBL] [Abstract][Full Text] [Related]
9. Development of a database on key characteristics of human carcinogens.
Al-Zoughool M; Bird M; Rice J; Baan RA; Billard M; Birkett N; Krewski D; Zielinski JM
J Toxicol Environ Health B Crit Rev; 2019; 22(7-8):264-287. PubMed ID: 31379270
[TBL] [Abstract][Full Text] [Related]
10. Prioritizing Chemicals for Risk Assessment Using Chemoinformatics: Examples from the IARC Monographs on Pesticides.
Guha N; Guyton KZ; Loomis D; Barupal DK
Environ Health Perspect; 2016 Dec; 124(12):1823-1829. PubMed ID: 27164621
[TBL] [Abstract][Full Text] [Related]
11. Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis.
Smith MT; Guyton KZ; Gibbons CF; Fritz JM; Portier CJ; Rusyn I; DeMarini DM; Caldwell JC; Kavlock RJ; Lambert PF; Hecht SS; Bucher JR; Stewart BW; Baan RA; Cogliano VJ; Straif K
Environ Health Perspect; 2016 Jun; 124(6):713-21. PubMed ID: 26600562
[TBL] [Abstract][Full Text] [Related]
12. Improving the International Agency for Research on Cancer's consideration of mechanistic evidence.
Goodman J; Lynch H
Toxicol Appl Pharmacol; 2017 Mar; 319():39-46. PubMed ID: 28162991
[TBL] [Abstract][Full Text] [Related]
13. Recommendations for further revisions to improve the International Agency for Research on Cancer (IARC) Monograph program.
Goodman JE; Mayfield DB; Becker RA; Hartigan SB; Erraguntla NK
Regul Toxicol Pharmacol; 2020 Jun; 113():104639. PubMed ID: 32147291
[TBL] [Abstract][Full Text] [Related]
14. Mycotoxins as human carcinogens-the IARC Monographs classification.
Ostry V; Malir F; Toman J; Grosse Y
Mycotoxin Res; 2017 Feb; 33(1):65-73. PubMed ID: 27888487
[TBL] [Abstract][Full Text] [Related]
15. The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard Identification.
Samet JM; Chiu WA; Cogliano V; Jinot J; Kriebel D; Lunn RM; Beland FA; Bero L; Browne P; Fritschi L; Kanno J; Lachenmeier DW; Lan Q; Lasfargues G; Le Curieux F; Peters S; Shubat P; Sone H; White MC; Williamson J; Yakubovskaya M; Siemiatycki J; White PA; Guyton KZ; Schubauer-Berigan MK; Hall AL; Grosse Y; Bouvard V; Benbrahim-Tallaa L; El Ghissassi F; Lauby-Secretan B; Armstrong B; Saracci R; Zavadil J; Straif K; Wild CP
J Natl Cancer Inst; 2020 Jan; 112(1):30-37. PubMed ID: 31498409
[TBL] [Abstract][Full Text] [Related]
16. Man-made mineral (vitreous) fibres: evaluations of cancer hazards by the IARC Monographs Programme.
Baan RA; Grosse Y
Mutat Res; 2004 Sep; 553(1-2):43-58. PubMed ID: 15288532
[TBL] [Abstract][Full Text] [Related]
17. Research Recommendations for Selected IARC-Classified Agents: Impact and Lessons Learned.
Turner MC; Cogliano V; Guyton K; Madia F; Straif K; Ward EM; Schubauer-Berigan MK
Environ Health Perspect; 2023 Oct; 131(10):105001. PubMed ID: 37902675
[TBL] [Abstract][Full Text] [Related]
18. Automated Network Assembly of Mechanistic Literature for Informed Evidence Identification to Support Cancer Risk Assessment.
Scholten B; Simón LG; Krishnan S; Vermeulen R; Pronk A; Gyori BM; Bachman JA; Vlaanderen J; Stierum R
Environ Health Perspect; 2022 Mar; 130(3):37002. PubMed ID: 35238605
[TBL] [Abstract][Full Text] [Related]
19. Use of mechanistic data in IARC evaluations.
Cogliano VJ; Baan RA; Straif K; Grosse Y; Secretan B; El Ghissassi F
Environ Mol Mutagen; 2008 Mar; 49(2):100-9. PubMed ID: 18240161
[TBL] [Abstract][Full Text] [Related]
20. Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans.
Krewski D; Rice JM; Bird M; Milton B; Collins B; Lajoie P; Billard M; Grosse Y; Cogliano VJ; Caldwell JC; Rusyn II; Portier CJ; Melnick RL; Baan RA; Little J; Zielinski JM
J Toxicol Environ Health B Crit Rev; 2019; 22(7-8):203-236. PubMed ID: 31795923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
